Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$79.4 - $116.36 $831,715 - $1.22 Million
10,475 New
10,475 $835,000
Q2 2021

Aug 11, 2021

SELL
$86.24 - $95.92 $2.03 Million - $2.26 Million
-23,562 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $6.83 Million - $9.08 Million
-95,055 Reduced 80.14%
23,562 $2.17 Million
Q4 2020

Feb 16, 2021

BUY
$67.0 - $84.39 $7.95 Million - $10 Million
118,617 New
118,617 $8.68 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.